{"id":17146,"date":"2021-03-01T15:11:33","date_gmt":"2021-03-01T14:11:33","guid":{"rendered":"http:\/\/mabdesign.fr\/mcsaf-obtained-a-patent-for-dar-4-antibody-drug-conjugates-technology\/"},"modified":"2023-10-17T10:49:32","modified_gmt":"2023-10-17T08:49:32","slug":"mcsaf-obtained-a-patent-for-dar-4-antibody-drug-conjugates-technology","status":"publish","type":"post","link":"https:\/\/mabdesign.fr\/en\/mcsaf-obtained-a-patent-for-dar-4-antibody-drug-conjugates-technology\/","title":{"rendered":"McSAF obtained a patent for DAR 4 antibody-drug conjugates technology"},"content":{"rendered":"<p><img decoding=\"async\" class=\"alignleft size-full wp-image-1672\" src=\"http:\/\/mabdesign.fr\/wp-content\/uploads\/2023\/10\/McSAF-72dpi.png\" alt=\"\" width=\"171\" height=\"60\" \/>\u00a0Tours, France &#8211; 25 F\u00e9v 2021 &#8211; The European Patent Office (EPO) has granted the patent number EP3521314 on the <a href=\"https:\/\/mcsaf.fr\/\" target=\"_blank\" rel=\"noopener noreferrer\">McSAF<\/a> Inside\u00ae technology to access DAR 4 antibody-drug conjugates, an emerging class of targeted medicines. This completes the portfolio of granted patents in France (FR3008408), Japan (JP6533222) and United States of America (US10307488). This is an essential asset for McSAF to become a key player in the bioconjugation field in the future. <a href=\"http:\/\/mabdesign.fr\/wp-content\/uploads\/2021\/03\/20210225-Press-Release-McSAF.pdf\" target=\"_blank\" rel=\"noopener noreferrer\">To know more<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"<p>The European Patent Office (EPO) has granted the patent number EP3521314 on the McSAF Inside\u00ae technology to access DAR 4 antibody-drug conjugates, an emerging class of targeted medicines. This is an essential asset for McSAF to become a key player in the bioconjugation field in the future.<\/p>\n","protected":false},"author":1,"featured_media":9380,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[36,32,18],"tags":[],"class_list":["post-17146","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-news","category-our-members","category-uncategorized"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v25.8 - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>McSAF obtained a patent for DAR 4 antibody-drug conjugates technology - MabDesign<\/title>\n<meta name=\"description\" content=\"The European Patent Office (EPO) has granted the patent number EP3521314 on the McSAF Inside\u00ae technology to access DAR 4 antibody-drug conjugates, an emerging class of targeted medicines. This is an essential asset for McSAF to become a key player in the bioconjugation field in the future.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/mabdesign.fr\/en\/mcsaf-obtained-a-patent-for-dar-4-antibody-drug-conjugates-technology\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"McSAF obtained a patent for DAR 4 antibody-drug conjugates technology - MabDesign\" \/>\n<meta property=\"og:description\" content=\"The European Patent Office (EPO) has granted the patent number EP3521314 on the McSAF Inside\u00ae technology to access DAR 4 antibody-drug conjugates, an emerging class of targeted medicines. This is an essential asset for McSAF to become a key player in the bioconjugation field in the future.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/mabdesign.fr\/en\/mcsaf-obtained-a-patent-for-dar-4-antibody-drug-conjugates-technology\/\" \/>\n<meta property=\"og:site_name\" content=\"MabDesign\" \/>\n<meta property=\"article:published_time\" content=\"2021-03-01T14:11:33+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2023-10-17T08:49:32+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/mabdesign.fr\/wp-content\/uploads\/2023\/10\/McSAF-72dpi.png\" \/>\n\t<meta property=\"og:image:width\" content=\"171\" \/>\n\t<meta property=\"og:image:height\" content=\"60\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/png\" \/>\n<meta name=\"author\" content=\"alexis.mathias@kairios.fr\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:creator\" content=\"@MabDesign_fr\" \/>\n<meta name=\"twitter:site\" content=\"@MabDesign_fr\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"alexis.mathias@kairios.fr\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/mabdesign.fr\/en\/mcsaf-obtained-a-patent-for-dar-4-antibody-drug-conjugates-technology\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/mabdesign.fr\/en\/mcsaf-obtained-a-patent-for-dar-4-antibody-drug-conjugates-technology\/\"},\"author\":{\"name\":\"alexis.mathias@kairios.fr\",\"@id\":\"https:\/\/mabdesign.fr\/en\/#\/schema\/person\/0a9d0510f7433c83f9e6974b2a9c0135\"},\"headline\":\"McSAF obtained a patent for DAR 4 antibody-drug conjugates technology\",\"datePublished\":\"2021-03-01T14:11:33+00:00\",\"dateModified\":\"2023-10-17T08:49:32+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/mabdesign.fr\/en\/mcsaf-obtained-a-patent-for-dar-4-antibody-drug-conjugates-technology\/\"},\"wordCount\":82,\"publisher\":{\"@id\":\"https:\/\/mabdesign.fr\/en\/#organization\"},\"image\":{\"@id\":\"https:\/\/mabdesign.fr\/en\/mcsaf-obtained-a-patent-for-dar-4-antibody-drug-conjugates-technology\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/mabdesign.fr\/wp-content\/uploads\/2023\/10\/McSAF-72dpi.png\",\"articleSection\":[\"News\",\"Our members\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/mabdesign.fr\/en\/mcsaf-obtained-a-patent-for-dar-4-antibody-drug-conjugates-technology\/\",\"url\":\"https:\/\/mabdesign.fr\/en\/mcsaf-obtained-a-patent-for-dar-4-antibody-drug-conjugates-technology\/\",\"name\":\"McSAF obtained a patent for DAR 4 antibody-drug conjugates technology - MabDesign\",\"isPartOf\":{\"@id\":\"https:\/\/mabdesign.fr\/en\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/mabdesign.fr\/en\/mcsaf-obtained-a-patent-for-dar-4-antibody-drug-conjugates-technology\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/mabdesign.fr\/en\/mcsaf-obtained-a-patent-for-dar-4-antibody-drug-conjugates-technology\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/mabdesign.fr\/wp-content\/uploads\/2023\/10\/McSAF-72dpi.png\",\"datePublished\":\"2021-03-01T14:11:33+00:00\",\"dateModified\":\"2023-10-17T08:49:32+00:00\",\"description\":\"The European Patent Office (EPO) has granted the patent number EP3521314 on the McSAF Inside\u00ae technology to access DAR 4 antibody-drug conjugates, an emerging class of targeted medicines. This is an essential asset for McSAF to become a key player in the bioconjugation field in the future.\",\"breadcrumb\":{\"@id\":\"https:\/\/mabdesign.fr\/en\/mcsaf-obtained-a-patent-for-dar-4-antibody-drug-conjugates-technology\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/mabdesign.fr\/en\/mcsaf-obtained-a-patent-for-dar-4-antibody-drug-conjugates-technology\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/mabdesign.fr\/en\/mcsaf-obtained-a-patent-for-dar-4-antibody-drug-conjugates-technology\/#primaryimage\",\"url\":\"https:\/\/mabdesign.fr\/wp-content\/uploads\/2023\/10\/McSAF-72dpi.png\",\"contentUrl\":\"https:\/\/mabdesign.fr\/wp-content\/uploads\/2023\/10\/McSAF-72dpi.png\",\"width\":171,\"height\":60},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/mabdesign.fr\/en\/mcsaf-obtained-a-patent-for-dar-4-antibody-drug-conjugates-technology\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Accueil\",\"item\":\"https:\/\/mabdesign.fr\/en\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"McSAF obtained a patent for DAR 4 antibody-drug conjugates technology\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/mabdesign.fr\/en\/#website\",\"url\":\"https:\/\/mabdesign.fr\/en\/\",\"name\":\"Mabdesign\",\"description\":\"The Biotherapy Expert\",\"publisher\":{\"@id\":\"https:\/\/mabdesign.fr\/en\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/mabdesign.fr\/en\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/mabdesign.fr\/en\/#organization\",\"name\":\"Mabdesign\",\"url\":\"https:\/\/mabdesign.fr\/en\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/mabdesign.fr\/en\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/mabdesign.fr\/wp-content\/uploads\/2022\/11\/logo-mabdesign.png\",\"contentUrl\":\"https:\/\/mabdesign.fr\/wp-content\/uploads\/2022\/11\/logo-mabdesign.png\",\"width\":786,\"height\":233,\"caption\":\"Mabdesign\"},\"image\":{\"@id\":\"https:\/\/mabdesign.fr\/en\/#\/schema\/logo\/image\/\"},\"sameAs\":[\"https:\/\/x.com\/MabDesign_fr\",\"https:\/\/www.linkedin.com\/company\/mabdesign\/\"]},{\"@type\":\"Person\",\"@id\":\"https:\/\/mabdesign.fr\/en\/#\/schema\/person\/0a9d0510f7433c83f9e6974b2a9c0135\",\"name\":\"alexis.mathias@kairios.fr\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/mabdesign.fr\/en\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/9f0235d3b23103c20120728bbe93c75ab83e508d42949114def0b4d989a03f94?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/9f0235d3b23103c20120728bbe93c75ab83e508d42949114def0b4d989a03f94?s=96&d=mm&r=g\",\"caption\":\"alexis.mathias@kairios.fr\"},\"sameAs\":[\"http:\/\/mabdesign.fr\"],\"url\":\"https:\/\/mabdesign.fr\/en\/author\/amathiasigtcreative-fr\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"McSAF obtained a patent for DAR 4 antibody-drug conjugates technology - MabDesign","description":"The European Patent Office (EPO) has granted the patent number EP3521314 on the McSAF Inside\u00ae technology to access DAR 4 antibody-drug conjugates, an emerging class of targeted medicines. This is an essential asset for McSAF to become a key player in the bioconjugation field in the future.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/mabdesign.fr\/en\/mcsaf-obtained-a-patent-for-dar-4-antibody-drug-conjugates-technology\/","og_locale":"en_US","og_type":"article","og_title":"McSAF obtained a patent for DAR 4 antibody-drug conjugates technology - MabDesign","og_description":"The European Patent Office (EPO) has granted the patent number EP3521314 on the McSAF Inside\u00ae technology to access DAR 4 antibody-drug conjugates, an emerging class of targeted medicines. This is an essential asset for McSAF to become a key player in the bioconjugation field in the future.","og_url":"https:\/\/mabdesign.fr\/en\/mcsaf-obtained-a-patent-for-dar-4-antibody-drug-conjugates-technology\/","og_site_name":"MabDesign","article_published_time":"2021-03-01T14:11:33+00:00","article_modified_time":"2023-10-17T08:49:32+00:00","og_image":[{"width":171,"height":60,"url":"https:\/\/mabdesign.fr\/wp-content\/uploads\/2023\/10\/McSAF-72dpi.png","type":"image\/png"}],"author":"alexis.mathias@kairios.fr","twitter_card":"summary_large_image","twitter_creator":"@MabDesign_fr","twitter_site":"@MabDesign_fr","twitter_misc":{"Written by":"alexis.mathias@kairios.fr"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/mabdesign.fr\/en\/mcsaf-obtained-a-patent-for-dar-4-antibody-drug-conjugates-technology\/#article","isPartOf":{"@id":"https:\/\/mabdesign.fr\/en\/mcsaf-obtained-a-patent-for-dar-4-antibody-drug-conjugates-technology\/"},"author":{"name":"alexis.mathias@kairios.fr","@id":"https:\/\/mabdesign.fr\/en\/#\/schema\/person\/0a9d0510f7433c83f9e6974b2a9c0135"},"headline":"McSAF obtained a patent for DAR 4 antibody-drug conjugates technology","datePublished":"2021-03-01T14:11:33+00:00","dateModified":"2023-10-17T08:49:32+00:00","mainEntityOfPage":{"@id":"https:\/\/mabdesign.fr\/en\/mcsaf-obtained-a-patent-for-dar-4-antibody-drug-conjugates-technology\/"},"wordCount":82,"publisher":{"@id":"https:\/\/mabdesign.fr\/en\/#organization"},"image":{"@id":"https:\/\/mabdesign.fr\/en\/mcsaf-obtained-a-patent-for-dar-4-antibody-drug-conjugates-technology\/#primaryimage"},"thumbnailUrl":"https:\/\/mabdesign.fr\/wp-content\/uploads\/2023\/10\/McSAF-72dpi.png","articleSection":["News","Our members"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/mabdesign.fr\/en\/mcsaf-obtained-a-patent-for-dar-4-antibody-drug-conjugates-technology\/","url":"https:\/\/mabdesign.fr\/en\/mcsaf-obtained-a-patent-for-dar-4-antibody-drug-conjugates-technology\/","name":"McSAF obtained a patent for DAR 4 antibody-drug conjugates technology - MabDesign","isPartOf":{"@id":"https:\/\/mabdesign.fr\/en\/#website"},"primaryImageOfPage":{"@id":"https:\/\/mabdesign.fr\/en\/mcsaf-obtained-a-patent-for-dar-4-antibody-drug-conjugates-technology\/#primaryimage"},"image":{"@id":"https:\/\/mabdesign.fr\/en\/mcsaf-obtained-a-patent-for-dar-4-antibody-drug-conjugates-technology\/#primaryimage"},"thumbnailUrl":"https:\/\/mabdesign.fr\/wp-content\/uploads\/2023\/10\/McSAF-72dpi.png","datePublished":"2021-03-01T14:11:33+00:00","dateModified":"2023-10-17T08:49:32+00:00","description":"The European Patent Office (EPO) has granted the patent number EP3521314 on the McSAF Inside\u00ae technology to access DAR 4 antibody-drug conjugates, an emerging class of targeted medicines. This is an essential asset for McSAF to become a key player in the bioconjugation field in the future.","breadcrumb":{"@id":"https:\/\/mabdesign.fr\/en\/mcsaf-obtained-a-patent-for-dar-4-antibody-drug-conjugates-technology\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/mabdesign.fr\/en\/mcsaf-obtained-a-patent-for-dar-4-antibody-drug-conjugates-technology\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/mabdesign.fr\/en\/mcsaf-obtained-a-patent-for-dar-4-antibody-drug-conjugates-technology\/#primaryimage","url":"https:\/\/mabdesign.fr\/wp-content\/uploads\/2023\/10\/McSAF-72dpi.png","contentUrl":"https:\/\/mabdesign.fr\/wp-content\/uploads\/2023\/10\/McSAF-72dpi.png","width":171,"height":60},{"@type":"BreadcrumbList","@id":"https:\/\/mabdesign.fr\/en\/mcsaf-obtained-a-patent-for-dar-4-antibody-drug-conjugates-technology\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Accueil","item":"https:\/\/mabdesign.fr\/en\/"},{"@type":"ListItem","position":2,"name":"McSAF obtained a patent for DAR 4 antibody-drug conjugates technology"}]},{"@type":"WebSite","@id":"https:\/\/mabdesign.fr\/en\/#website","url":"https:\/\/mabdesign.fr\/en\/","name":"Mabdesign","description":"The Biotherapy Expert","publisher":{"@id":"https:\/\/mabdesign.fr\/en\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/mabdesign.fr\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/mabdesign.fr\/en\/#organization","name":"Mabdesign","url":"https:\/\/mabdesign.fr\/en\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/mabdesign.fr\/en\/#\/schema\/logo\/image\/","url":"https:\/\/mabdesign.fr\/wp-content\/uploads\/2022\/11\/logo-mabdesign.png","contentUrl":"https:\/\/mabdesign.fr\/wp-content\/uploads\/2022\/11\/logo-mabdesign.png","width":786,"height":233,"caption":"Mabdesign"},"image":{"@id":"https:\/\/mabdesign.fr\/en\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/x.com\/MabDesign_fr","https:\/\/www.linkedin.com\/company\/mabdesign\/"]},{"@type":"Person","@id":"https:\/\/mabdesign.fr\/en\/#\/schema\/person\/0a9d0510f7433c83f9e6974b2a9c0135","name":"alexis.mathias@kairios.fr","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/mabdesign.fr\/en\/#\/schema\/person\/image\/","url":"https:\/\/secure.gravatar.com\/avatar\/9f0235d3b23103c20120728bbe93c75ab83e508d42949114def0b4d989a03f94?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/9f0235d3b23103c20120728bbe93c75ab83e508d42949114def0b4d989a03f94?s=96&d=mm&r=g","caption":"alexis.mathias@kairios.fr"},"sameAs":["http:\/\/mabdesign.fr"],"url":"https:\/\/mabdesign.fr\/en\/author\/amathiasigtcreative-fr\/"}]}},"_links":{"self":[{"href":"https:\/\/mabdesign.fr\/en\/wp-json\/wp\/v2\/posts\/17146","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/mabdesign.fr\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/mabdesign.fr\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/mabdesign.fr\/en\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/mabdesign.fr\/en\/wp-json\/wp\/v2\/comments?post=17146"}],"version-history":[{"count":0,"href":"https:\/\/mabdesign.fr\/en\/wp-json\/wp\/v2\/posts\/17146\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/mabdesign.fr\/en\/wp-json\/wp\/v2\/media\/9380"}],"wp:attachment":[{"href":"https:\/\/mabdesign.fr\/en\/wp-json\/wp\/v2\/media?parent=17146"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/mabdesign.fr\/en\/wp-json\/wp\/v2\/categories?post=17146"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/mabdesign.fr\/en\/wp-json\/wp\/v2\/tags?post=17146"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}